204 related articles for article (PubMed ID: 28377931)
21. Plant-derived Compounds as Potential Source of Novel Anti-Biofilm Agents Against Pseudomonas aeruginosa.
Chung PY
Curr Drug Targets; 2017; 18(4):414-420. PubMed ID: 27758704
[TBL] [Abstract][Full Text] [Related]
22. The Herba Patriniae (Caprifoliaceae): A review on traditional uses, phytochemistry, pharmacology and quality control.
Gong L; Zou W; Zheng K; Shi B; Liu M
J Ethnopharmacol; 2021 Jan; 265():113264. PubMed ID: 32846192
[TBL] [Abstract][Full Text] [Related]
23. Antipathogenic potential of Rhizophora spp. against the quorum sensing mediated virulence factors production in drug resistant Pseudomonas aeruginosa.
Annapoorani A; Kalpana B; Musthafa KS; Pandian SK; Ravi AV
Phytomedicine; 2013 Aug; 20(11):956-63. PubMed ID: 23746758
[TBL] [Abstract][Full Text] [Related]
24. Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities.
Tolker-Nielsen T
APMIS Suppl; 2014 Dec; (138):1-51. PubMed ID: 25399808
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic characterization of multidrug-resistant Pseudomonas aeruginosa strains isolated from pediatric patients associated to biofilm formation.
Ochoa SA; Cruz-Córdova A; Rodea GE; Cázares-Domínguez V; Escalona G; Arellano-Galindo J; Hernández-Castro R; Reyes-López A; Xicohtencatl-Cortes J
Microbiol Res; 2015 Mar; 172():68-78. PubMed ID: 25530579
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial and Antibiofilm Activity and Machine Learning Classification Analysis of Essential Oils from Different Mediterranean Plants against Pseudomonas aeruginosa.
Artini M; Patsilinakos A; Papa R; Božović M; Sabatino M; Garzoli S; Vrenna G; Tilotta M; Pepi F; Ragno R; Selan L
Molecules; 2018 Feb; 23(2):. PubMed ID: 29473844
[No Abstract] [Full Text] [Related]
27. Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control.
Bjarnsholt T; Tolker-Nielsen T; Høiby N; Givskov M
Expert Rev Mol Med; 2010 Apr; 12():e11. PubMed ID: 20370936
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and biological evaluation of 2-substituted 3-hydroxy-6-methyl-4H-pyran-4-one derivatives as Pseudomonas aeruginosa biofilm inhibitors.
Li YB; Liu J; Huang ZX; Yu JH; Xu XF; Sun PH; Lin J; Chen WM
Eur J Med Chem; 2018 Oct; 158():753-766. PubMed ID: 30245399
[TBL] [Abstract][Full Text] [Related]
29. Combined treatment of Pseudomonas aeruginosa PA01 biofilm formation with the water-soluble extract of Ligustrum sinense and gentamicin sulphate.
Yang DM; Ouyang MA; Lv SQ
J Environ Biol; 2013 Apr; 34(2 Spec No):451-7. PubMed ID: 24620617
[TBL] [Abstract][Full Text] [Related]
30. Anti-Pseudomonas aeruginosa activity of 1,10-phenanthroline-based drugs against both planktonic- and biofilm-growing cells.
Viganor L; Galdino AC; Nunes AP; Santos KR; Branquinha MH; Devereux M; Kellett A; McCann M; Santos AL
J Antimicrob Chemother; 2016 Jan; 71(1):128-34. PubMed ID: 26416778
[TBL] [Abstract][Full Text] [Related]
31. Crataeva nurvala nanoparticles inhibit virulence factors and biofilm formation in clinical isolates of Pseudomonas aeruginosa.
Ali SG; Ansari MA; Khan HM; Jalal M; Mahdi AA; Cameotra SS
J Basic Microbiol; 2017 Mar; 57(3):193-203. PubMed ID: 27874198
[TBL] [Abstract][Full Text] [Related]
32. Anti-biofilm activity of Marula - a study with the standardized bark extract.
Sarkar R; Chaudhary SK; Sharma A; Yadav KK; Nema NK; Sekhoacha M; Karmakar S; Braga FC; Matsabisa MG; Mukherjee PK; Sen T
J Ethnopharmacol; 2014 May; 154(1):170-5. PubMed ID: 24742751
[TBL] [Abstract][Full Text] [Related]
33. Cranberry proanthocyanidins have anti-biofilm properties against Pseudomonas aeruginosa.
Ulrey RK; Barksdale SM; Zhou W; van Hoek ML
BMC Complement Altern Med; 2014 Dec; 14():499. PubMed ID: 25511463
[TBL] [Abstract][Full Text] [Related]
34. Explorative gene analysis of antibiotic tolerance-related genes in adherent and biofilm cells of Pseudomonas aeruginosa.
Murakami K; Ono T; Noma Y; Minase I; Amoh T; Irie Y; Hirota K; Miyake Y
J Infect Chemother; 2017 May; 23(5):271-277. PubMed ID: 28274550
[TBL] [Abstract][Full Text] [Related]
35. Influence of Melaleuca alternifolia oil nanoparticles on aspects of Pseudomonas aeruginosa biofilm.
Comin VM; Lopes LQ; Quatrin PM; de Souza ME; Bonez PC; Pintos FG; Raffin RP; Vaucher Rde A; Martinez DS; Santos RC
Microb Pathog; 2016 Apr; 93():120-5. PubMed ID: 26821356
[TBL] [Abstract][Full Text] [Related]
36. Novel therapeutic strategies to counter Pseudomonas aeruginosa infections.
Fothergill JL; Winstanley C; James CE
Expert Rev Anti Infect Ther; 2012 Feb; 10(2):219-35. PubMed ID: 22339195
[TBL] [Abstract][Full Text] [Related]
37. Reprint of “Inhibition of biofilm formation by Camelid single-domainantibodies against the flagellum of Pseudomonas aeruginosa”.
Adams H; Horrevoets WM; Adema SM; Carr HE; van Woerden RE; Koster M; Tommassen J
J Biotechnol; 2014 Dec; 191():131-8. PubMed ID: 25450637
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental model.
Elkhatib W; Noreddin A
Microb Drug Resist; 2014 Dec; 20(6):575-82. PubMed ID: 25050970
[TBL] [Abstract][Full Text] [Related]
40. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
Saini H; Chhibber S; Harjai K
Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
